Company / Assets per Share
Editas Medicine, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.25
FY2025
5-year range
$2.25 / $10.83
FY2021-FY2025
Trend
-46.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 4 consecutive years, from $10.83 in FY2021 to $2.25 in FY2025.
Based on SEC 10-K filings.
2.25 in FY2025 with a 5-year CAGR of -26.5%.
Declined from $7.25 to $2.25 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -33.1%
- 5-Year CAGR
- -26.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Editas Medicine, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 46.0% year-over-year.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.25 | -46.0% |
| FY2024 | $4.18 | -42.4% |
| FY2023 | $7.25 | -3.5% |
| FY2022 | $7.52 | -30.6% |
| FY2021 | $10.83 | +2.8% |
| FY2020 | $10.53 | +0.9% |
| FY2019 | $10.44 | +10.5% |
| FY2018 | $9.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026